Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1966]

Crystallography of the B-cell receptor immunoglobulin in CLL patients

Prof Paolo Ghia - San Raffaele University, Milan, Italy

Crystallography of the B-cell receptor immunoglobulin in CLL patients ( Prof Paolo Ghia - San Raffaele University, Milan, Italy )

Results of a new phase Ib trial of voxtalisib in combination with...

Prof Farrukh Awan - Ohio State University, Columbus, USA

Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )

A laboratory model of the hypoxic tumour microenvironment

Dr Giles Best - Royal North Shore Hospital, Sydney, Australia

A laboratory model of the hypoxic tumour microenvironment ( Dr Giles Best - Royal North Shore Hospital, Sydney, Australia )

Will chemotherapy remain the cornerstone of CLL management?

Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany

Will chemotherapy remain the cornerstone of CLL management? ( Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany )

Phase II study of idelalisib monotherapy in older CLL patients

Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA

Phase II study of idelalisib monotherapy in older CLL patients ( Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA )

History of the B-cell in its 50th anniversary year

Prof Max Cooper - Emory University, Atlanta, USA

History of the B-cell in its 50th anniversary year ( Prof Max Cooper - Emory University, Atlanta, USA )

Human B-cell receptor structure and function in CLL

Prof Freda Stevenson - University of Southampton, Southampton, UK

Human B-cell receptor structure and function in CLL ( Prof Freda Stevenson - University of Southampton, Southampton, UK )

Aspirin for cancer treatment and prevention

Prof Peter Elwood – Cardiff University, Cardiff, UK

Aspirin for cancer treatment and prevention ( Prof Peter Elwood – Cardiff University, Cardiff, UK )

ecancermedicalscience editor's choice for August 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience editor's choice for August 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Immune tolerance and the microenvironment in head and neck cancer

Prof Gilberto de Castro - Instituto do Cancer do Estado de Sao Paulo, Sao Paulo...

Immune tolerance and the microenvironment in head and neck cancer ( Prof Gilberto de Castro - Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil )

Preventive measures and immunology in head and neck cancer

Dr Fernando Cotait Maluf - Oncologia Clínica do Centro Oncológico Antônio...

Preventive measures and immunology in head and neck cancer ( Dr Fernando Cotait Maluf - Oncologia Clínica do Centro Oncológico Antônio Ermírio de Moraes, Sao Paulo, Brazil )

De-activating chromosomes to prevent cancer

Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy

De-activating chromosomes to prevent cancer ( Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy )

More from ecancer